Nav: Home

Tulane researchers help find possible explanation for unparalleled spread of Ebola virus

June 06, 2017

The world may be closer to knowing why Ebola spreads so easily thanks to a team of researchers from Tulane University and other leading institutions who discovered a new biological activity in a small protein from the deadly virus. The team's findings were recently published in the Journal of Virology.

The discovery comes as health workers try to contain another Ebola outbreak in a remote area of the Democratic Republic of the Congo. Ebola, which is highly fatal, causes severe vomiting, internal bleeding and extreme gastrointestinal distress.

A compound known as the "delta peptide" is produced in large amounts in Ebola virus-infected patients, but its function isn't yet known. The investigators tested the effects of purified delta peptide on cells from humans and other mammals and found that it could be a viroporin, a type of viral protein that damages host cells by making the membranes become permeable.

"Our leading hypothesis is that the delta peptide affects the gastrointestinal tract by damaging cells after its release from infected cells," says William Wimley, George A. Adrouny Professor of Biochemistry and Molecular Biology at Tulane University School of Medicine. "This effect may be a major contributor to the severe GI illness of patients with the Ebola virus."

During the West African Ebola that began in late 2013, the virus spread rapidly principally because of the presence of the virus in GI fluids. The lack of effective countermeasures led to the death of more than 11,000 people.

Tulane researchers say the immediate next step is to begin developing therapies that target the delta peptide.

The research involved laboratories from Tulane University School of Medicine, which participated in the fight against Ebola virus on the front lines in Sierra Leone during the outbreak, as well as researchers from Johns Hopkins University and the Louisiana State University Health Sciences Center.
-end-


Tulane University

Related Ebola Articles:

Ebola survivors have a 'unique' retinal scar
Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye using an ultra widefield retinal camera.
Ebola: Lives to be saved with new management approach
Ebola outbreaks are set to be managed quickly and efficiently -- saving lives -- with a new approach developed by an international team of researchers, including the University of Warwick, which helps to streamline outbreak decision-making.
Ebola vaccines provide immune responses after 1 year
Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.
New scoring system predicts Ebola severity
While Ebola virus disease (EVD) is notorious for being one of the world's most deadly infections, it actually has a wide range of outcomes, where asymptomatic presentation may be as common as fatality.
Could co-infection with other viruses affect the survival of those with Ebola virus?
Could co-infection with other viruses have a detrimental affect on Ebola survival, and why did some show Ebola symptoms without having the virus?
Antimalarial being tested as possible Ebola virus drug
The National Center for Advancing Translational Sciences (NCATS) recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc.
Ebola map may help prepare for future outbreaks
To be prepared for new Ebola virus disease cases, it is fundamental to start by identifying the range of the virus and the regions that are more favorable for its propagation.
Sexual transmission of Ebola likely to impact course of outbreaks
Sexual transmission of the Ebola virus could have a major impact on the dynamics of the disease, potentially reigniting an outbreak that has been contained by public health interventions, according to research by University of Georgia ecologists just published in the Royal Society journal Biology Letters.
Ebola vaccine: Promising phase I trials
The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe.
Improving treatments for post-Ebola syndrome sufferers
Researchers from the University of Liverpool and the King's Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week.

Related Ebola Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...